| scholarly article | Q13442814 |
| P50 | author | Jeremy Farrar | Q15967402 |
| Tran Tinh Hien | Q30004272 | ||
| Tran Nguyen Bich Chau | Q30004278 | ||
| Cameron P. Simmons | Q37392993 | ||
| Katherine L. Anders | Q57306561 | ||
| Marcel Wolbers | Q59593777 | ||
| Stephen S Whitehead | Q64866574 | ||
| Hung Thanh Nguyen | Q87493661 | ||
| Bich Lien Nguyen | Q96050458 | ||
| P2093 | author name string | Nguyen Trong Hieu | |
| Lu Thi Minh Hieu | |||
| P2860 | cites work | Diagnostic Accuracy of NS1 ELISA and Lateral Flow Rapid Tests for Dengue Sensitivity, Specificity and Relationship to Viraemia and Antibody Responses | Q27487547 |
| Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity | Q27489388 | ||
| Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored | Q27489549 | ||
| A prospective study of dengue infections in Bangkok | Q28296365 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
| A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. | Q30778819 | ||
| Maternal antibody and viral factors in the pathogenesis of dengue virus in infants | Q35097469 | ||
| B-cell responses to vaccination at the extremes of age. | Q37400606 | ||
| Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study | Q38874657 | ||
| Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children | Q39348179 | ||
| Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam | Q39519199 | ||
| Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. | Q40390836 | ||
| Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. | Q40481758 | ||
| Transplacentally transferred maternal-infant antibodies to dengue virus. | Q40550295 | ||
| Assessment of the factors associated with flavivirus seroprevalence in a population in Southern Vietnam | Q40582541 | ||
| Risk factors in dengue shock syndrome. | Q40651443 | ||
| Placental passage of antibodies to Dengue virus in persons living in a region of hyperendemic Dengue virus infection | Q40897110 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Dengue virus | Q476209 | ||
| birth cohort | Q64532946 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1893-1900 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants | |
| P478 | volume | 200 |
| Q64986771 | A Stillborn Multiple Organs' Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization. |
| Q35011189 | A birth cohort study of viral infections in Vietnamese infants and children: study design, methods and characteristics of the cohort |
| Q47156413 | A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus |
| Q91212064 | Adaptive immune responses to primary and secondary dengue virus infections |
| Q36931818 | Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo |
| Q47592202 | Antibody-dependent enhancement of severe dengue disease in humans |
| Q26859651 | Approaches to refining estimates of global burden and economics of dengue |
| Q28730914 | Assessing the potential of a candidate dengue vaccine with mathematical modeling |
| Q92860639 | Bayley III in Vietnamese children: lessons for cross-cultural comparisons |
| Q34289194 | CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice |
| Q54238236 | Challenges in dengue research: A computational perspective |
| Q27491351 | Clinical and Virological Features of Dengue in Vietnamese Infants |
| Q34146653 | Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project |
| Q35781863 | Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM |
| Q35065632 | Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study |
| Q40316344 | Decay and persistence of maternal dengue antibodies among infants in Bangkok |
| Q91271250 | Dengue |
| Q39348151 | Dengue Antibody in Thai Children From Maternally Transferred Antibody to Acquired Infection |
| Q40128790 | Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes. |
| Q33389194 | Dengue in infants: an overview |
| Q88536628 | Dengue vaccination during pregnancy - An overview of clinical trials data |
| Q34117580 | Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection |
| Q38158411 | Dengue virus infection: current concepts in immune mechanisms and lessons from murine models |
| Q27026302 | Dengue viruses - an overview |
| Q35294150 | Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera |
| Q28729764 | Dengue: knowledge gaps, unmet needs, and research priorities |
| Q64099613 | Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines |
| Q40294304 | Enhanced humoral and HLA‐A2‐restricted dengue virus‐specific T‐cell responses in humanized BLT NSG mice |
| Q21131163 | Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections |
| Q33428741 | Epidemiology of Dengue Among Children Aged < 18 Months-Puerto Rico, 1999-2011. |
| Q35866928 | Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics |
| Q34766904 | Estimates of dengue force of infection in children in Colombo, Sri Lanka |
| Q31156754 | First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies |
| Q28943386 | Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1 |
| Q47558315 | Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity |
| Q34976206 | Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody |
| Q37827145 | Immune Response to Dengue Virus and Prospects for a Vaccine |
| Q38652971 | Immune correlates of protection for dengue: State of the art and research agenda |
| Q37828333 | Important Advances in the Field of Anti-Dengue Virus Research |
| Q41935971 | Incidence and risk factors for Dengue virus (DENV) infection in the first 2 years of life in a Brazilian prospective birth cohort |
| Q33588528 | Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam. |
| Q36615111 | Lessons from malaria control to help meet the rising challenge of dengue |
| Q39329367 | Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement |
| Q33430984 | Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage |
| Q59245659 | Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice |
| Q56395792 | Methods to discriminate primary from secondary dengue during acute symptomatic infection |
| Q36026321 | Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance |
| Q27010151 | Mouse models to study dengue virus immunology and pathogenesis |
| Q35058877 | Neutralizing dengue antibody in pregnant Thai women and cord blood |
| Q37033074 | Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants |
| Q92119891 | Plans for Nationwide Serosurveillance Network in Vietnam |
| Q38919411 | Prospective birth cohort in a hyperendemic dengue area in Northeast Brazil: methods and preliminary results |
| Q36234359 | Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection |
| Q90109621 | Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia |
| Q39576880 | Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection |
| Q33414560 | Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice |
| Q47136667 | TLR2/MyD88 pathway-dependent regulation of dendritic cells by dengue virus promotes antibody-dependent enhancement via Th2-biased immunity |
| Q37987124 | The Human Antibody Response to Dengue Virus Infection |
| Q36012107 | The Role of Serotype Interactions and Seasonality in Dengue Model Selection and Control: Insights from a Pattern Matching Approach |
| Q37448171 | The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity |
| Q37904027 | The pathogenesis of dengue |
| Q33954195 | The role of climate variability and change in the transmission dynamics and geographic distribution of dengue |
| Q28742723 | The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam |
| Q41991852 | Transfer of maternal immunity and programming of the newborn immune system. |
| Q34516283 | Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination |
| Q39653165 | Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity |
| Q66679277 | Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice |
Search more.